logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Abercrombie, Ian
    Ceo born in June 1961
    Individual (3 offsprings)
    Officer
    icon of calendar 2022-02-02 ~ now
    OF - Director → CIF 0
  • 2
    Lipman, Keith
    Company Director born in June 1971
    Individual (14 offsprings)
    Officer
    icon of calendar 2015-07-27 ~ now
    OF - Director → CIF 0
  • 3
    Wood, Christopher Barry, Prof
    Doctor born in December 1945
    Individual (18 offsprings)
    Officer
    icon of calendar 2006-05-07 ~ now
    OF - Director → CIF 0
    Mr Christopher Barry Wood
    Born in December 1945
    Individual (18 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 4
    Hanna, Wilfred Sydney
    Company Director born in April 1967
    Individual (17 offsprings)
    Officer
    icon of calendar 2015-07-27 ~ now
    OF - Director → CIF 0
  • 5
    Smith, Stuart William Gordon, Doctor
    Director born in January 1961
    Individual (6 offsprings)
    Officer
    icon of calendar 2005-10-12 ~ now
    OF - Director → CIF 0
Ceased 6
  • 1
    Quinn, Martin
    Individual (16 offsprings)
    Officer
    icon of calendar 2016-01-27 ~ 2019-07-22
    OF - Secretary → CIF 0
  • 2
    Nelson, Thomas Scott
    Director born in March 1939
    Individual
    Officer
    icon of calendar 2006-11-01 ~ 2022-06-30
    OF - Director → CIF 0
  • 3
    Smith, Stuart William Gordon, Doctor
    Individual (6 offsprings)
    Officer
    icon of calendar 2006-05-10 ~ 2016-01-27
    OF - Secretary → CIF 0
  • 4
    Smith, Sandra
    Individual
    Officer
    icon of calendar 2005-11-21 ~ 2006-05-10
    OF - Secretary → CIF 0
  • 5
    COMLAW DIRECTOR LIMITED - 2000-11-06
    icon of address4th Floor, Saltire Court, 20 Castle Terrace, Edinburgh, Lothian
    Dissolved Corporate (3 parents, 34 offsprings)
    Officer
    2005-07-29 ~ 2005-10-13
    PE - Nominee Director → CIF 0
  • 6
    icon of address4th Floor, Saltire Court, 20 Castle Terrace, Edinburgh, Lothian
    Dissolved Corporate (3 parents, 84 offsprings)
    Officer
    2005-07-29 ~ 2005-11-21
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

ONCOBIOPHARM LIMITED

Previous names
NUCANA BIOPHARMACEUTICALS LIMITED - 2008-07-02
NUCANA LIMITED - 2006-11-02
DUNWILCO (1277) LIMITED - 2005-10-14
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
180,069 GBP2024-09-30
207,402 GBP2023-09-30
Fixed Assets - Investments
1 GBP2024-09-30
1 GBP2023-09-30
Fixed Assets
180,070 GBP2024-09-30
207,403 GBP2023-09-30
Debtors
138,914 GBP2024-09-30
104,171 GBP2023-09-30
Cash at bank and in hand
4,449 GBP2024-09-30
33,198 GBP2023-09-30
Current Assets
143,363 GBP2024-09-30
137,369 GBP2023-09-30
Net Current Assets/Liabilities
81,025 GBP2024-09-30
93,976 GBP2023-09-30
Total Assets Less Current Liabilities
261,095 GBP2024-09-30
301,379 GBP2023-09-30
Equity
Called up share capital
201,255 GBP2024-09-30
201,255 GBP2023-09-30
Share premium
3,155,054 GBP2024-09-30
3,155,054 GBP2023-09-30
Retained earnings (accumulated losses)
-3,095,214 GBP2024-09-30
-3,054,930 GBP2023-09-30
Equity
261,095 GBP2024-09-30
301,379 GBP2023-09-30
Average Number of Employees
52023-10-01 ~ 2024-09-30
72022-10-01 ~ 2023-09-30
Intangible Assets - Gross Cost
Other than goodwill
428,285 GBP2023-09-30
Intangible Assets - Accumulated Amortisation & Impairment
Other than goodwill
248,216 GBP2024-09-30
220,883 GBP2023-09-30
Intangible Assets - Increase From Amortisation Charge for Year
Other than goodwill
27,333 GBP2023-10-01 ~ 2024-09-30
Intangible Assets
Other than goodwill
180,069 GBP2024-09-30
207,402 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
Computers
9,116 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
9,116 GBP2023-09-30
Property, Plant & Equipment
Computers
0 GBP2024-09-30
0 GBP2023-09-30
Investments in group undertakings and participating interests
1 GBP2024-09-30
1 GBP2023-09-30
Amounts Owed By Related Parties
130,183 GBP2024-09-30
Current
94,581 GBP2023-09-30
Other Debtors
Amounts falling due within one year
8,731 GBP2024-09-30
9,590 GBP2023-09-30
Debtors
Current, Amounts falling due within one year
138,914 GBP2024-09-30
104,171 GBP2023-09-30
Trade Creditors/Trade Payables
Current
438 GBP2024-09-30
10,459 GBP2023-09-30
Other Taxation & Social Security Payable
Current
145 GBP2024-09-30
383 GBP2023-09-30
Other Creditors
Current
61,755 GBP2024-09-30
32,551 GBP2023-09-30
Creditors
Current
62,338 GBP2024-09-30
43,393 GBP2023-09-30
Par Value of Share
Class 1 ordinary share
0 GBP2023-10-01 ~ 2024-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
40,251,103 shares2024-09-30
40,251,103 shares2023-09-30

Related profiles found in government register
  • ONCOBIOPHARM LIMITED
    Info
    NUCANA BIOPHARMACEUTICALS LIMITED - 2008-07-02
    NUCANA LIMITED - 2006-11-02
    DUNWILCO (1277) LIMITED - 2005-10-14
    Registered number SC288225
    icon of address1 Lochrin Square, 92-98 Fountainbridge, Edinburgh EH3 9QA
    Private Limited Company incorporated on 2005-07-29 (20 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-29
    CIF 0
  • ONCOBIOPHARM LIMITED
    S
    Registered number Sc288225
    icon of address1, Lochrin Square, 92-98 Fountainbridge, Edinburgh, Scotland, EH3 9QA
    Limited Company in Uk Companies House, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • icon of address1 Lochrin Square, 92-98 Fountainbridge, Edinburgh, Scotland
    Active Corporate (3 parents)
    Equity (Company account)
    -128,463 GBP2024-09-30
    Person with significant control
    icon of calendar 2019-10-01 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.